Management of Lactational Mastitis: Advice for Patients

Lactational mastitis is a common condition that affects breastfeeding women. It is important to manage this condition promptly to prevent complications such as breast abscesses. Here are some management options for lactational mastitis:

1. Advise her to continue breastfeeding and start empirical antibiotics: If the patient presents with lactational mastitis and has a nipple fissure, it is suggestive of an infective cause. In this case, the patient should be reassured, asked to continue breastfeeding, offered adequate analgesia, and started on empirical antibiotics.

2. Reassure the patient, ask her to continue expressing milk and review if there is no improvement in two days: If there is no evidence of infection, reassurance and advice to continue breastfeeding, as well as simple analgesia, are a good first management option. However, if symptoms do not improve in 24 hours, then there is an indication for starting empirical antibiotics.

3. Admit the patient to hospital for intravenous antibiotics and drainage: Admission is advisable for intravenous antibiotics and drainage if oral antibiotics fail to improve symptoms, the patient develops sepsis, or there is evidence of the development of a breast abscess.

4. Advise her to continue breastfeeding and send a breast milk culture and treat if positive: A breast milk culture should be sent before starting antibiotics, but in this case, given the patient fulfils the criteria for starting empirical treatment, you should not delay antibiotic therapy until the breast milk culture is back.

5. Reassure the patient, advise her to continue breastfeeding and offer simple analgesia: Reassurance, advice to continue breastfeeding, and simple analgesia are offered to women who first present with lactational mastitis. If symptoms do not improve after three days, there is an indication to offer empirical antibiotics.

In conclusion, lactational mastitis should be managed promptly to prevent complications. Patients should be advised to continue breastfeeding, offered adequate analgesia, and started on empirical antibiotics if necessary. If symptoms do not improve, further management options should be considered.

Labetalol is the recommended first-line treatment for pregnancy-induced hypertension. This is because the patient in question has developed new-onset stage I hypertension after 20 weeks of gestation, indicating gestational hypertension. As there is no proteinuria present, pre-eclampsia is not suspected. According to NICE guidelines from 2019, medical treatment should be initiated if blood pressure remains elevated above 140/90 mmHg. Nifedipine is a second-line treatment option if labetalol is not suitable or well-tolerated. Methyldopa is also a viable option if labetalol or nifedipine are not appropriate. Amlodipine, on the other hand, lacks sufficient data to support its safety during pregnancy.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, and age over 40. Aspirin may be recommended for women with high or moderate risk factors. Treatment involves emergency assessment, admission for observation, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

Pregnancy-induced hypertension is typically treated with Labetalol as the initial medication.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, and age over 40. Aspirin may be recommended for women with high or moderate risk factors. Treatment involves emergency assessment, admission for observation, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

Recommendations for Feeding Low-Birthweight Infants

Low-birthweight infants, those with a birthweight of less than 2,500 g, should be exclusively breastfed for the first six months of life, according to WHO recommendations. If the mother’s milk is not available, donor human milk should be sought. If that is not possible, standard formula milk can be used. There is no difference in the duration of exclusive breastfeeding between low-birthweight and normal-weight infants. Daily vitamin A supplementation is not currently recommended for low-birthweight infants, but very low-birthweight infants should receive daily supplementation of vitamin D, calcium, and phosphorus. Low-birthweight infants who are able to breastfeed should start as soon as possible after birth, once they are clinically stable.

In case of suspected rubella during pregnancy, it is important to consult with the local Health Protection Unit for guidance on appropriate investigations to conduct. If the mother is found to be non-immune to rubella, the MMR vaccine should be administered after childbirth, although the risk of transmission to the fetus is uncertain. If transmission does occur, particularly during this stage of pregnancy, it can cause significant harm to the developing fetus. Hospitalization is not necessary at this point.

Rubella and Pregnancy: Risks, Features, Diagnosis, and Management

Rubella, also known as German measles, is a viral infection caused by the togavirus. Thanks to the introduction of the MMR vaccine, it is now rare. However, if contracted during pregnancy, there is a risk of congenital rubella syndrome, which can cause serious harm to the fetus. It is important to note that the incubation period is 14-21 days, and individuals are infectious from 7 days before symptoms appear to 4 days after the onset of the rash.

The risk of damage to the fetus is highest in the first 8-10 weeks of pregnancy, with a risk as high as 90%. However, damage is rare after 16 weeks. Features of congenital rubella syndrome include sensorineural deafness, congenital cataracts, congenital heart disease (e.g. patent ductus arteriosus), growth retardation, hepatosplenomegaly, purpuric skin lesions, ‘salt and pepper’ chorioretinitis, microphthalmia, and cerebral palsy.

If a suspected case of rubella in pregnancy arises, it should be discussed immediately with the local Health Protection Unit (HPU) as type/timing of investigations may vary. IgM antibodies are raised in women recently exposed to the virus. It should be noted that it is very difficult to distinguish rubella from parvovirus B19 clinically. Therefore, it is important to also check parvovirus B19 serology as there is a 30% risk of transplacental infection, with a 5-10% risk of fetal loss.

If a woman is tested at any point and no immunity is demonstrated, they should be advised to keep away from people who might have rubella. Non-immune mothers should be offered the MMR vaccination in the post-natal period. However, MMR vaccines should not be administered to women known to be pregnant or attempting to become pregnant.

The correct diagnosis in this case is chronic hypertension. It is unlikely that the patient has developed any pregnancy-related causes of hypertension at only 16 weeks gestation. The small amount of protein in her urine suggests that she may have had hypertension for some time. The patient’s intermittent frontal headaches are a common occurrence and do not indicate pre-eclampsia. Pre-eclampsia and gestational hypertension typically occur after 20 weeks gestation, with pre-eclampsia being associated with significant proteinuria and gestational hypertension without. Nephrotic syndrome would typically present with a larger degree of proteinuria.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

Genital herpes is caused by herpes simplex type 1 or 2 and can harm newborns, leading to neonatal herpes. Pregnant women who contract herpes and remain untreated have a higher risk of premature delivery and membrane rupture. Therefore, it is crucial to promptly treat women with herpes simplex infection. acyclovir is a safe treatment option, which speeds up the healing process and suppresses viral shedding. Women with primary herpes infection in the first and second trimesters should be treated with oral acyclovir and offered treatment-dose acyclovir from the 36th week of gestation until delivery to prevent recurrence and reduce the risk of neonatal herpes. Expectant delivery is acceptable in these cases. Women who acquire herpes in the third trimester should be treated with acyclovir until delivery and offered an elective Caesarean section to reduce the risk of neonatal transmission. Women who have acquired a primary genital herpes infection in the first and second trimesters that was treated should be offered acyclovir from 36 weeks onwards to reduce the risk of recurrence, lesion eruption, and viral shedding. Women with primary herpes simplex virus infection in labor who opt for vaginal delivery should receive intravenous acyclovir infusion to reduce the risk of neonatal herpes infection. Invasive procedures should be avoided in these cases.

Common Tumor Markers and their Clinical Significance

Beta human chorionic gonadotropin (β-HCG)
β-HCG levels are monitored in cases of molar pregnancy, which can present with morning sickness and symptoms of hyperthyroidism due to high levels of HCG. Monitoring levels of β-HCG is important to ensure that no fetal tissue remains after treatment to minimise the risk of developing choriocarcinoma or a persistent mole.

Alpha fetoprotein (AFP)
AFP is a marker used to screen for neural tube defects, hepatocellular carcinoma and endodermal sinus tumours.

CA-125
CA-125 is a marker of ovarian malignancy. Although it is used to monitor response to chemotherapy and tumour recurrence, it has not been widely used as a screening tool.

Lactate dehydrogenase (LDH)
Increased LDH is strongly associated with dysgerminomas.

Oestriol
Urine unconjugated oestriol is measured as part of the quadruple screen for trisomy 21. Low levels of oestriol are suggestive of Down syndrome.

Understanding Tumor Markers and their Clinical Implications

If lochia continues for more than 6 weeks, an ultrasound should be performed.

During the puerperium, which is the period of around 6 weeks after childbirth when the woman’s reproductive organs return to their normal state, lochia is the discharge of blood, mucous, and uterine tissue that occurs. It is expected to stop after 4-6 weeks. However, if it persists beyond this time, an ultrasound is necessary to investigate the possibility of retained products of conception.

Lochia refers to the discharge that is released from the vagina after childbirth. This discharge is composed of blood, mucous, and uterine tissue. It is a normal occurrence that can last for up to six weeks following delivery. During this time, the body is working to heal and recover from the physical changes that occurred during pregnancy and childbirth. It is important for new mothers to monitor their lochia and report any unusual changes or symptoms to their healthcare provider.

The recommended first line treatment for moderate to severe depression in pregnancy or post-natal period for women without a history of severe depression is a high intensity psychological intervention, such as CBT, according to the National Institute for Health and Care Excellence. If this is not accepted or symptoms do not improve, an antidepressant such as a selective serotonin re-uptake inhibitor (SSRI) or tricyclic antidepressant (TCA) should be used. Mindfulness may be helpful for women with persistent subclinical depressive symptoms. Social services should only be involved if there is a risk to someone in the household. The British National Formulary (BNF) advises against using zopiclone while breastfeeding as it is present in breast milk.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

Repair of third degree perineal tears should be carried out in a theatre by a clinician who has received appropriate training. This is because category 3 and 4 tears pose a risk of infection and have a significant impact on the patient’s health. Poor healing of perineal wounds can lead to faecal incontinence, which is a potential complication of grade 3 and 4 tears. It is advisable to pack the perineal wound for haemostasis before repairing the tear, as this will help achieve better haemostasis with sutures. Healing of perineal tears by secondary intent is not recommended, as it can result in poor healing, infection, and faecal incontinence. Additionally, the vascular nature of the perineum and anus increases the likelihood of ongoing haemorrhage if the wound is not healed. In cases of category 1 and 2 tears (involving the skin only or skin and perineal muscle), perineal tear repair can be performed immediately on the maternity ward if the clinician feels comfortable and there is adequate lighting.

Perineal tears are a common occurrence during childbirth, and the Royal College of Obstetricians and Gynaecologists (RCOG) has developed guidelines to classify them based on their severity. First-degree tears are superficial and do not require any repair, while second-degree tears involve the perineal muscle and require suturing by a midwife or clinician. Third-degree tears involve the anal sphincter complex and require repair in theatre by a trained clinician, with subcategories based on the extent of the tear. Fourth-degree tears involve the anal sphincter complex and rectal mucosa and also require repair in theatre by a trained clinician.

There are several risk factors for perineal tears, including being a first-time mother, having a large baby, experiencing a precipitant labour, and having a shoulder dystocia or forceps delivery. It is important for healthcare providers to be aware of these risk factors and to provide appropriate care and management during childbirth to minimize the risk of perineal tears. By following the RCOG guidelines and providing timely and effective treatment, healthcare providers can help ensure the best possible outcomes for both mother and baby.

It should be noted that the woman already had hypertension before becoming pregnant. Blood pressure issues related to pregnancy, such as pre-eclampsia or pregnancy-induced hypertension, typically do not occur until after 20 weeks of gestation. The elevated blood pressure readings obtained through ambulatory monitoring rule out the possibility of white-coat hypertension. It is important to note that the term pre-existing hypertension is used instead of essential hypertension, as high blood pressure in a woman of this age is uncommon and may indicate secondary hypertension.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

As a medical student, you may not be required to interpret fetal CTGs, but you should have a basic understanding of their purpose and key features. A CTG measures fetal heart rate and uterine contractions and is used when there are risk factors for fetal hypoxia. While CTGs are not specific and can lead to increased medical intervention, changes in fetal heart rate should be taken seriously as they indicate fetal distress.

To interpret a CTG, you can use the mnemonic DR C BRA VADO. DR stands for defining the patient’s risk factors for being on a CTG monitor, while C refers to counting the number of contractions in 10 minutes. BRA stands for baseline rate and variability, with a normal fetal baseline rate being 110-160 beats per minute and variability ranging from 5 to 25 beats per minute. A refers to accelerations, which are rises in fetal heart rate, and D refers to decelerations, which are reductions in fetal heart rate. Late decelerations, which are slow to recover, are particularly concerning as they indicate fetal hypoxia.

As a medical student, it is important to be aware of terminal bradycardia and terminal decelerations, which are indicators for emergency caesarean section. Other changes in CTG features are usually investigated with fetal scalp blood sampling and an ABG to check for acidosis. The NICE guidelines provide a useful table for interpreting CTG features and determining appropriate management, ranging from normal care to urgent intervention.

Cardiotocography (CTG) is a medical procedure that measures pressure changes in the uterus using either internal or external pressure transducers. It is used to monitor the fetal heart rate, which normally ranges between 100-160 beats per minute. There are several features that can be observed during a CTG, including baseline bradycardia (heart rate below 100 beats per minute), which can be caused by increased fetal vagal tone or maternal beta-blocker use. Baseline tachycardia (heart rate above 160 beats per minute) can be caused by maternal pyrexia, chorioamnionitis, hypoxia, or prematurity. Loss of baseline variability (less than 5 beats per minute) can be caused by prematurity or hypoxia. Early deceleration, which is a decrease in heart rate that starts with the onset of a contraction and returns to normal after the contraction, is usually harmless and indicates head compression. Late deceleration, on the other hand, is a decrease in heart rate that lags behind the onset of a contraction and does not return to normal until after 30 seconds following the end of the contraction. This can indicate fetal distress, such as asphyxia or placental insufficiency. Variable decelerations, which are independent of contractions, may indicate cord compression.

Shoulder dystocia is more likely to occur in women with diabetes mellitus. However, using forceps during delivery to pull the baby out can increase the risk of injury to the baby and cause brachial plexus injury. Therefore, it is important to consider alternative delivery methods before resorting to forceps.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the fetus. Risk factors for shoulder dystocia include fetal macrosomia, high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior help immediately. The McRoberts’ maneuver is often performed, which involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant maternal morbidity. Oxytocin administration is not indicated for shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury and neonatal death for the fetus. It is important to manage shoulder dystocia promptly and appropriately to minimize the risk of these complications.

To determine if induction is necessary, the Bishop scoring system evaluates cervical characteristics such as position, consistency, effacement, dilation, and foetal station. If the score is less than 5, induction is likely required. However, if the score is above 9, spontaneous labour is expected.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.

The primary treatment for nausea and vomiting during pregnancy, including hyperemesis gravidarum, is antihistamines.

Hyperemesis gravidarum is an extreme form of nausea and vomiting of pregnancy that occurs in around 1% of pregnancies and is most common between 8 and 12 weeks. It is associated with raised beta hCG levels and can be caused by multiple pregnancies, trophoblastic disease, hyperthyroidism, nulliparity, and obesity. Referral criteria for nausea and vomiting in pregnancy include continued symptoms with ketonuria and/or weight loss, a confirmed or suspected comorbidity, and inability to keep down liquids or oral antiemetics. The diagnosis of hyperemesis gravidarum requires the presence of 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance. Management includes first-line use of antihistamines and oral cyclizine or promethazine, with second-line options of ondansetron and metoclopramide. Admission may be needed for IV hydration. Complications can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth issues.

The primary concern in eclampsia is to manage seizures, which can be prevented and treated with magnesium sulphate as the first-line treatment. If magnesium sulphate is not available or ineffective, benzodiazepines like midazolam can be considered. Additionally, due to high blood pressure, antihypertensive drugs like Labetalol, Hydralazine, and Nifedipine are administered during pregnancy as they are effective and have low teratogenicity. Starting low dose aspirin before 16 weeks of gestation has been shown to significantly reduce the risk of pre-eclampsia.

Understanding Eclampsia and its Treatment

Eclampsia is a condition that occurs when seizures develop in association with pre-eclampsia, a pregnancy-induced hypertension that is characterized by proteinuria and occurs after 20 weeks of gestation. To prevent seizures in patients with severe pre-eclampsia and treat seizures once they develop, magnesium sulphate is commonly used. However, it is important to note that this medication should only be given once a decision to deliver has been made. In cases of eclampsia, an IV bolus of 4g over 5-10 minutes should be given, followed by an infusion of 1g/hour. During treatment, it is crucial to monitor urine output, reflexes, respiratory rate, and oxygen saturations. Respiratory depression can occur, and calcium gluconate is the first-line treatment for magnesium sulphate-induced respiratory depression. Treatment should continue for 24 hours after the last seizure or delivery, as around 40% of seizures occur post-partum. Additionally, fluid restriction is necessary to avoid the potentially serious consequences of fluid overload.

In summary, understanding the development of eclampsia and its treatment is crucial in managing this potentially life-threatening condition. Magnesium sulphate is the primary medication used to prevent and treat seizures, but it should only be given once a decision to deliver has been made. Monitoring vital signs and urine output is essential during treatment, and calcium gluconate should be readily available in case of respiratory depression. Finally, fluid restriction is necessary to avoid complications associated with fluid overload.

Rhesus negative pregnancies can lead to the formation of anti-D IgG antibodies in the mother if she delivers a Rh +ve child, which can cause haemolysis in future pregnancies. Prevention involves testing for D antibodies and giving anti-D prophylaxis to non-sensitised Rh -ve mothers at 28 and 34 weeks. Anti-D immunoglobulin should be given within 72 hours in various situations. Tests should be done on all babies born to Rh -ve mothers, and affected fetuses may experience various complications and require treatment such as transfusions and UV phototherapy.

Common Oral Abnormalities in Infants: Tongue Tie, Upper Lip Tie, Cleft Lip, and Cleft Palate

Tongue tie, also known as ankyloglossia, is a condition that affects up to 10% of live births, more commonly in boys than girls. It is characterized by a short, thickened frenulum attaching the tongue to the floor of the mouth, limiting tongue movements and causing difficulties with breastfeeding. Mothers may report that their infant takes a long time to feed, is irritable, and experiences nipple injury. Examination findings include limited tongue movements, inability to lift the tongue high or move it past the lower lip, and a characteristic heart-shaped notch when attempting to lift the tongue. Tongue tie can be anterior or posterior, with the latter being deeper in the mouth and more difficult to see.

Upper lip tie is a similar condition, with a frenulum attaching the upper lip to the gum line. This can also cause difficulties with breastfeeding due to limited movement of the upper lip.

Cleft lip and cleft palate are congenital malformations that occur when the facial structures fail to fuse properly during development. Cleft lip presents as a gap in the upper lip, while cleft palate is a gap in the roof of the mouth. Both can cause difficulties with feeding and require surgical intervention.

It is important for healthcare providers to be aware of these common oral abnormalities in infants and provide appropriate management and referrals to ensure optimal feeding and development.

When inducing labour in a patient who is past her due date, the main complication to watch out for is uterine hyperstimulation. The recommended method for inducing labour according to NICE guidelines is vaginal prostaglandins, which can be administered as a gel, tablet or slow-release pessary. A membrane sweep may also be performed alongside this. Vaginal prostaglandins work by ripening the cervix and stimulating uterine contractions. If uterine hyperstimulation occurs, tocolytic agents can be given to relax the uterus and slow contractions. It’s important to note that a breech presentation is not a complication of induction of labour, especially in cases where the foetus is stationed in the pelvis below the ischial spines. Chorioamnionitis, which is inflammation of the foetal membranes due to bacterial infection, is a risk during prolonged labour and repeated vaginal examinations, but it is not the main complication of induction of labour. Cord prolapse is also a possible complication, but it is more common when the presenting part of the foetus is high, which is not the case in this pregnancy where the foetal head is stationed 1 cm below the ischial spine.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.